Shilpa Medicare Limited (NSE: SHILPAMED) secures final approval for OERISTM, the world's first extended-release ondansetron injection, marking a significant.
Fabtech Technologies Limited (FABTECH) completes 14,000 sqm turnkey facility for Himalaya Wellness Company in UAE, showcasing engineering capabilities.
Alkem Laboratories Limited (ALKEM) launches Renocia Exo™, India’s first patented Ginsenoside exosome-based hair growth serum, addressing hair loss with regen.
Biocon Limited (BIOCON) secures a 10-year supply contract for Pertuzumab in Brazil, marking a significant milestone in advancing HER2-positive breast cancer.
Lupin Limited (LUPIN) secures U.S. FDA approval for Modafinil Tablets, expanding its generics portfolio with a bioequivalent to Provigil®.
Aster DM Quality Care Limited (ASTERDM) sees Dr. Moopen family increase stake by ~₹350 crore, raising their shareholding to 24.58%.
Cipla Limited (CIPLA) announces a strategic partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to Keytruda® in the US.
Cohance Lifesciences Limited (COHANCE) announced an additional USD 13 million investment in NJ Bio and USD 5 million in Aruka Bio to strengthen its Antibody-.
Max Healthcare Institute Limited unveils new 400 beds tower at Max Smart Super Speciality Hospital, Saket, expanding its capacity to 1,200 beds.
Suven Life Sciences Limited (SUVEN) completes patient enrollment in global Phase-3 study of Masupirdine for agitation associated with Alzheimer’s Dementia.